Magnesium: Clinical Trials

21 trials of Magnesium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 3 terminated, 2 unknown, 1 active not recruiting. 21 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 321Completed 12, Terminated 3, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 26Completed 4, Active not recruiting 1, Terminated 1

Follow Magnesium: new trials by email Literature Review of Magnesium trials Research Report on Magnesium

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
Magnesium, Placebo - Migraine
Phase 3RecruitingWake Forest University Health Sciences1002025-12-162026-01-22
Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine
Propranolol 80 mg, Magnesium 400Mg - Migraine, Nutraceuticals
Phase 3Not yet recruitingFayoum University1002025-08-202025-08-29
Oral Intake of Mg in Controlled Asthmatic Patients
Magnesium, ICS+LABA - Bronchial Asthma
Phase 2 / Phase 3Active not recruitingZagazig University1662024-11-022025-08-14
Efficacy of Bupivacaine-magnesium Combination Versus Bupivacaine Alone in Genicular Nerve Block
genicular nerve block using bupivacaine and magnesium, genicular nerve block using bupivacaine and normal saline - Post Operative Pain
Phase 3CompletedCairo University942024-08-012025-11-17
Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis
Transcranial Magnetic Stimulation, Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule - Multiple Sclerosis, Fatigue
Phase 3UnknownHospital San Carlos, Madrid1442022-11-282023-12-11
Peri-Operative Magnesium Infusion to Prevent Atrial Fibrillation Evaluated.
Magnesium sulfate - Atrial Fibrillation New Onset
Phase 2 / Phase 3TerminatedHagaZiekenhuis2652022-08-012024-08-28
MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)
Magnesium, Placebo Oral Tablet - Alcohol Withdrawal Syndrome
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1052017-11-162021-12-21
Effect of Magnesium Supplement in Early Pregnancy After ICSI
Magnesium Oxide, Placebo Oral Tablet - ICSI
Phase 3UnknownAin Shams University1802017-06-012018-01-12
Analgesic Efficacy of Two Adjuvants During Spinal Anaesthesia.
Saline Solution, Magnesium Sulfate, Midazolam 5 MG/ML Injection - Pain, Postoperative
Phase 2 / Phase 3CompletedCentre de Maternité de Monastir1502017-02-012018-03-08
MLD10 in the Prevention of Migraine in Adults
MLD10, Placebo - Migraine
Phase 2 / Phase 3CompletedPharmalyte Solutions LLC1572015-03-012020-10-09
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Hydralazine/Magnesium, Placebo, Carboplatin - Cervical Cancer
Phase 3WithdrawnNational Institute of Cancerología2015-01-012025-05-29
Magnesium vs Placebo for Tonsillectomy
Magnesium, Normal saline - Pain
Phase 2 / Phase 3CompletedAnn & Robert H Lurie Children's Hospital of Chicago602014-10-012019-01-03
The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Compound Natural Health Product, Placebo - Attention Deficit Hyperactivity Disorder
Phase 3CompletedThe Canadian College of Naturopathic Medicine162013-11-012016-01-28
A Trial of Magnesium Dependent Tinnitus
Magnesium, Placebo - Tinnitus
Phase 3CompletedMayo Clinic382011-07-012015-04-30
Tepilta® Versus Oxetacaine, Antacids and Placebo
oxetacaine, aluminium and magnesium hydroxide, oxetacaine, magnesium and aluminium hydroxide - Radiation-induced Oesophagitis
Phase 3TerminatedMEDA Pharma GmbH & Co. KG402011-04-012022-02-07
Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity
Glutamine, Calcium and Magnesium - Colorectal Neoplasms
Phase 3CompletedSanofi2002010-02-012013-06-21
Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Zinc, Magnesium, Vitamin B6, Vitamin C (Compound Natural Health Product for ADHD) - Attention Deficit Hyperactivity Disorder
Phase 2 / Phase 3CompletedKieran Cooley282008-09-012015-10-19
Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population
Magnesium, Nifedlipine - Labor, Premature
Phase 3TerminatedMemorialCare2002008-03-012009-09-18
EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
ANTOX (vers.)1.2, Magnesium, Placebo ANTOX (vers)1.2 - Pancreatitis
Phase 3CompletedUniversity Medicine Greifswald2952005-06-062020-03-27
Magnesium Effects in Apheresis
magnesium - Healthy
Phase 3CompletedNational Institutes of Health Clinical Center (CC)522002-06-012008-03-04

Showing 20 of 21. Sign in to see all of them.

Conditions studied

Migraine Disorders (3)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  Impulsive Behavior (2)  ·  Pain (2)  ·  Pain, Postoperative (2)  ·  Alcoholism (1)  ·  Asthma (1)  ·  Cardiovascular Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Coronary Disease (1)  ·  Delirium (1)  ·  Fatigue (1)  ·  Heart Diseases (1)  ·  Hereditary pancreatitis (1)  ·  Hypocalcemia (1)

Sponsors

Ain Shams University (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cairo University (1)  ·  Centre de Maternité de Monastir (1)  ·  Fayoum University (1)  ·  HagaZiekenhuis (1)  ·  Hospital San Carlos, Madrid (1)  ·  Kieran Cooley (1)  ·  MEDA Pharma GmbH & Co. KG (1)  ·  Mayo Clinic (1)  ·  MemorialCare (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  National Institute of Cancerología (1)  ·  National Institutes of Health Clinical Center (CC) (1)

Countries

United States (6)  ·  Canada (3)  ·  Egypt (3)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Tunisia (1)

Top investigators

Umesh Jain, MD (2)  ·  Cetina Lucely, MSc (1)  ·  Christopher Halloran, Professor,MD,FRCS (1)  ·  Frank Bruns, Dr. med. (1)  ·  Heather Boon, PhD (1)  ·  Hubert A Benzon, MD, MPH (1)  ·  Jeroen Ludikhuize, MD, PhD (1)  ·  Jorge Matias-Guiu Guia, MD PhD (1)  ·  Julia V Mayerle, Professor,MD (1)  ·  Kenneth Chan, MD (1)  ·  Markus M Lerch, Professor,MD (1)  ·  Michael Cevette, PhD (1)  ·  Rim Cherif, Dr. (1)

Results publications

PMID 35947046, PMID 38176857, PMID 39148128, PMID 42206948

NIH funding

2009 (1), 2016 (1)